Medindia LOGIN REGISTER
Medindia

For the First Time, Alzheimer's Drug Will be Funded in NZ

by Rajshri on May 6 2010 9:55 PM

 For the First Time, Alzheimer
Drug-buying agency Pharmac has announced that for the first time a medicine specifically targetting Alzheimer's Disease and dementia will be funded in New Zealand.
Pharmac revealed that it plans to buy the Donepezil Rex brand of medicines after the drug is registered with medicines safety regulator Medsafe. This decision was made because evidence indicates drugs belonging to the class of acetylchlorinesterase inhibitors may slow the progression of Alzheimer's in some patients.

Donepizil will become available without restriction to an estimated 15,000 people in the country after Pharmac managed to reduce the $32 million price tag on the drug by 95%.


Source-Medindia
RAS


Advertisement